These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10470900)

  • 41. Current status of intracavitary chemotherapy.
    Markman M
    Oncology (Williston Park); 1987 Mar; 1(1):25-30. PubMed ID: 3079474
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Huber needle in situ inpatients under continuous infusion chemotherapy: results of a study, Phase II].
    Milani A; Vernizzi S; Passoni C; Sociale O; Macciola F; Grimaldi C; Comensoli M; Peruzzotti G; Lunghi L; Colleoni M
    Prof Inferm; 2000; 53(2):71-4. PubMed ID: 11272087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Using n-butyl cyanoacrylate and the fixed-catheter-tip technique in percutaneous implantation of a port-catheter system in patients undergoing repeated hepatic arterial chemotherapy.
    Yamagami T; Iida S; Kato T; Tanaka O; Hirota T; Nakamura T; Nishimura T
    AJR Am J Roentgenol; 2002 Dec; 179(6):1611-7. PubMed ID: 12438064
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Home care utilizing silastic catheters.
    Terry J
    NITA; 1983; 6(5):348-50. PubMed ID: 6555608
    [No Abstract]   [Full Text] [Related]  

  • 45. Percutaneous placement of a venous access port in a pediatric patient population.
    Golladay ES; Mollitt DL
    J Pediatr Surg; 1986 Aug; 21(8):683-4. PubMed ID: 3746601
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A safe and simple method of percutaneous transfemoral implantation of a port-catheter access system for hepatic artery chemotherapy infusion].
    Kuroiwa T; Honda H; Yoshimitsu K; Irie H; Aibe H; Shinozaki K; Nishie A; Nakayama T; Masuda K
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1573-7. PubMed ID: 11707983
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Cytostatic agents administrated via a subcutaneous intravenous port: the course was a nightmare].
    Lakartidningen; 1995 May; 92(22):2300. PubMed ID: 7783488
    [No Abstract]   [Full Text] [Related]  

  • 48. Management and prevention of complications of subcutaneous intravenous infusion port.
    Jan HC; Chou SJ; Chen TH; Lee CI; Chen TK; Lou MA
    Surg Oncol; 2012 Mar; 21(1):7-13. PubMed ID: 20674336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of silicone elastomer catheters for long-term intravenous chemotherapy.
    Legha SS; Haq M; Rabinowits M; Lawson M; McCredie K
    Arch Intern Med; 1985 Jul; 145(7):1208-11. PubMed ID: 4015268
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of end hole in placement of port-catheter system for continuous hepatic arterial infusion chemotherapy using the fixed catheter tip method.
    Yamagami T; Kato T; Iida S; Hirota T; Nishimura T
    AJR Am J Roentgenol; 2005 Apr; 184(4):1332-9. PubMed ID: 15788620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Soft tissue-anchored transcutaneous port attached to an intestinal tube for long-term gastroduodenal infusion of levodopa/carbidopa in Parkinson disease.
    Nyman R; Lundgren D; Nyholm D
    J Vasc Interv Radiol; 2009 Apr; 20(4):500-5. PubMed ID: 19216094
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Phlebitogenicity of venous catheters of Vialon].
    Fassolt A
    Infusionsther Klin Ernahr; 1985 Dec; 12(6):282-6. PubMed ID: 4093198
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of N-butyl cyanoacrylate in implantation of a port-catheter system for hepatic arterial infusion chemotherapy with the fixed-catheter-tip method: is it necessary?
    Yamagami T; Terayama K; Yoshimatsu R; Matsumoto T; Miura H; Nishimura T
    AJR Am J Roentgenol; 2008 Nov; 191(5):1523-9. PubMed ID: 18941095
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The port: delivering intraperitoneal chemotherapy in ovarian cancer.
    Doane LS
    Todays OR Nurse; 1992 Sep; 14(9):11-8. PubMed ID: 1412628
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complications encountered with a transfemorally placed port-catheter system for hepatic artery chemotherapy infusion.
    Kuroiwa T; Honda H; Yoshimitsu K; Irie H; Aibe H; Tajima T; Shinozaki K; Masuda K
    Cardiovasc Intervent Radiol; 2001; 24(2):90-3. PubMed ID: 11443392
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Three cases of Pseudomyxoma peritonei treated with intraperitoneal inoculation of cisplatin through an implantable port system].
    Suzuki T; Umekita N; Inoue S; Miyamoto S; Maeshiro T; Awane Y
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1449-51. PubMed ID: 9703851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of a pull-through technique at the time of port-catheter implantation in cases of celiac arterial stenosis.
    Yamagami T; Kato T; Hirota T; Yoshimatsu R; Matsumoto T; Nishimura T
    J Vasc Interv Radiol; 2006 Nov; 17(11 Pt 1):1839-44. PubMed ID: 17142716
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A patient's guide to the implanted port.
    Kilbride SS
    Oncol Nurs Forum; 1986; 13(2):83-5. PubMed ID: 3633579
    [No Abstract]   [Full Text] [Related]  

  • 59. Home care of the Hickman/Broviac catheter.
    Daeffler RJ; Lewinski J
    Oncol Nurs Forum; 1982; 9(4):59-60. PubMed ID: 6923419
    [No Abstract]   [Full Text] [Related]  

  • 60. Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer.
    Black D; Levine DA; Nicoll L; Chou JF; Iasonos A; Brown CL; Sonoda Y; Chi DS; Leitao MM; Abu-Rustum NR; Ferguson SE; Barakat RR
    Gynecol Oncol; 2008 Apr; 109(1):39-42. PubMed ID: 18234300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.